Skip to main content
. 2020 May 4;20:320. doi: 10.1186/s12879-020-4932-0

Table 3.

Laboratory evaluation of the Deki Reader comparing device versus SOC results

Deki Reader Version RDT brand Result compared to SOC aConcordance n (%)
HIV positive HIV negative aSensitivity
% (95%CI)
aSpecificity
% (95%CI)
Deki & HCW invalid (true) Deki invalid (false)
True False True False
bV100

First Response® HIV-1-2-0

(n = 253)

128 118

100

(97.2–100)

100

(96.9–100)

7 253 (100)
Determine™ HIV-1/2 Ag/Ab Combo (n = 259) 135 c 2 94 d 1

99.3

(96.0–100)

97.9

(92.7–99.8)

27 256 (98.8)

e Uni-Gold HIV

(n = 262)

132 127 d 1

99.3

(95.9–100)

100

(97.1–100)

259 (99.6)
Overall (n = 772) 395 2 339 2

99.5

(98.2–99.9)

99.4

(97.9–99.9)

34 768 (99.5)
V200 First Response® HIV-1-2-0 (n = 158) 113 2 43

100

(96.8–100)

95.6

(84.9–99.5)

156 (98.7)
One Step Anti-HIV (1&2) (n = 158) 109 2 40

100

(96.7–100)

95.2

(83.8–99.4)

1 f 6 150 (94.9)

HIV 1/2/0 Tri-Line

(n = 158)

114 5 39

100

(96.8–100)

88.6

(75.4–96.2)

153 (96.8)
Overall (n = 474) 336 9 122

100

(98.9–100)

93.1

(87.4–96.8)

1 6 459 (96.8)

aConcordance includes invalid specimens, but excludes errors and specimens that were not processed. Sensitivity and specificity only includes specimens that gave a valid positive or negative result

bDeki Reader data was adjudicated by Fio as part of the process to optimise the output data (software optimisation)

cAir bubble over control line, linked to RDT

dLine < 50% of width, software adjustments required

eDeki Reader v100 error (n = 2)

fDeki Reader v200 invalid control line